These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 24712844)

  • 1. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Guo Y
    Neoplasma; 2014 Apr; ():. PubMed ID: 24712844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Guo Y
    Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of TBX2 expression in non-small cell lung cancer.
    Hu B; Mu HP; Zhang YQ; Su CY; Song JT; Meng C; Liu DX
    J Mol Histol; 2014 Aug; 45(4):421-6. PubMed ID: 24531749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Sam68 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Xu Y; Sun N; Zhang M; Xie J; Jiang Z
    Clin Transl Oncol; 2014 Oct; 16(10):886-91. PubMed ID: 24522888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of Cripto-1 correlates with poor prognosis in non-small cell lung cancer.
    Xu CH; Sheng ZH; Hu HD; Hao KK; Wang QB; Yu LK
    Tumour Biol; 2014 Sep; 35(9):8673-8. PubMed ID: 24870591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-box 2 expression predicts poor prognosis in gastric cancer.
    Yu H; Liu BO; Liu A; Li K; Zhao H
    Oncol Lett; 2015 Sep; 10(3):1689-1693. PubMed ID: 26622733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle-related and expression-elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non-small-cell lung cancer.
    Li W; Zheng G; Xia J; Yang G; Sun J; Wang X; Wen M; Sun Y; Zhang Z; Jin F
    Cancer Sci; 2018 Apr; 109(4):1012-1023. PubMed ID: 29397041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression level and prognostic value of HIPK3 among non-small-cell lung cancer patients in China.
    Liu Y; Qian L; Yang J; Huang H; Feng J; Li X; Bian T; Ke H; Liu J; Zhang J
    Onco Targets Ther; 2018; 11():7459-7469. PubMed ID: 30498360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of TBX2 and P21 expression with clinicopathological features and survival of laryngeal squamous cell carcinoma.
    Huang Y; Li Z; Zhong Q; Li G; Zhang Y; Huang Z
    Int J Clin Exp Med; 2014; 7(12):5394-402. PubMed ID: 25664048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sestrin2 expression is a favorable prognostic factor in patients with non-small cell lung cancer.
    Chen KB; Xuan Y; Shi WJ; Chi F; Xing R; Zeng YC
    Am J Transl Res; 2016; 8(4):1903-9. PubMed ID: 27186314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
    Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-1290 is a potential prognostic biomarker in non-small cell lung cancer.
    Mo D; Gu B; Gong X; Wu L; Wang H; Jiang Y; Zhang B; Zhang M; Zhang Y; Xu J; Pan S
    J Thorac Dis; 2015 Sep; 7(9):1570-9. PubMed ID: 26543604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of HMGB3 expression in patients with non-small cell lung cancer.
    Song N; Liu B; Wu JL; Zhang RF; Duan L; He WS; Zhang CM
    Tumour Biol; 2013 Oct; 34(5):2599-603. PubMed ID: 23609034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of long noncoding RNA uc.338 predicts poor survival in non-small cell lung cancer.
    Tian Y; Feng Y
    Cancer Biomark; 2018; 22(4):781-785. PubMed ID: 29843223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tazarotene-induced gene 2 is associated with poor survival in non-small cell lung cancer.
    Cai Q; Huang Z; Qi L; Wang T; Shen Y; Huang J
    Oncol Lett; 2016 Oct; 12(4):2680-2685. PubMed ID: 27698842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low claudin-6 expression correlates with poor prognosis in patients with non-small cell lung cancer.
    Wang Q; Zhang Y; Zhang T; Han ZG; Shan L
    Onco Targets Ther; 2015; 8():1971-7. PubMed ID: 26261421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpressed C14orf166 associates with disease progression and poor prognosis in non-small-cell lung cancer.
    Zhou YW; Li R; Duan CJ; Gao Y; Cheng YD; Zhang CF
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30126850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.